Edward P Armstrong
Overview
Explore the profile of Edward P Armstrong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
1071
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Armstrong E, Franic D, Malone D, Mellors P, Pham S, Masseria C, et al.
Leuk Res
. 2024 Sep;
147:107592.
PMID: 39341087
Background: Disease progression and poor prognosis in higher-risk (HR) myelodysplastic syndrome (MDS) create an urgent need for interventions to improve the patient care experience in this vulnerable population. Patient-centric physician-supported...
2.
Armstrong E, Malone D, Franic D, Pham S, Gratie D, Amin A
Infect Dis Ther
. 2023 Jul;
12(7):1775-1795.
PMID: 37395984
Introduction: Clostridioides difficile infection (CDI) is a globally recognized cause of morbidity and mortality with devastating effects on health-related quality of life (HRQoL). The objective of this study was to...
3.
Malone D, Armstrong E, Gratie D, Pham S, Amin A
Antimicrob Steward Healthc Epidemiol
. 2023 Jan;
3(1):e17.
PMID: 36714290
Objective: To conduct a systematic review of published real-world evidence describing the cost and healthcare resource use for infection (CDI) in the United States. Methods: A systematic literature review was...
4.
Meredith N, Armstrong E
Prev Med Rep
. 2022 Jul;
29:101923.
PMID: 35898193
The purpose of this study was to conduct a systematic review to evaluate the cost-effectiveness evidence of herpes zoster vaccines in the U.S. A systematic literature review was undertaken for...
5.
Kazerooni R, Armstrong E
Clin Drug Investig
. 2018 Nov;
38(12):1199-1200.
PMID: 30390199
No abstract available.
6.
Kazerooni R, Armstrong E
Clin Drug Investig
. 2018 Jun;
38(9):867-872.
PMID: 29926379
Introduction: Published literature on overdoses related to botulinum toxin A (BtxA) agents is scarce. Objective: The aim of this study was to assess the BtxA drug class' respective agents for...
7.
Chinthammit C, Rupp M, Armstrong E, Modisett T, Snead R, Warholak T
J Pharm Policy Pract
. 2017 Sep;
10:26.
PMID: 28878928
Background: The importance of creating and sustaining a strong culture of patient safety has been recognized as a critical component of safe medication use. This study aims to assess changes...
8.
Armstrong E, Malone D, Yeh W, Dahl G, Lee R, Sicignano N
J Med Econ
. 2016 Jun;
19(8):822-6.
PMID: 27264163
Aim: To evaluate the economic burden of spinal muscular atrophy (SMA). Materials And Methods: This study used Department of Defense Military Healthcare System (MHS) data from 2003-2012. Healthcare costs were...
9.
Yehoshua A, Chancellor M, Vasavada S, Malone D, Armstrong E, Joshi M, et al.
J Manag Care Spec Pharm
. 2016 Mar;
22(4):406-13.
PMID: 27023694
Background: Overactive bladder (OAB) is a common medical condition with significant economic and humanistic burden. Inadequately managed OAB may exacerbate or result in comorbidities such as depression, falls, and urinary...
10.
Tang D, Malone D, Warholak T, Chong J, Armstrong E, Slack M, et al.
J Clin Neurol
. 2015 May;
11(3):252-61.
PMID: 26022458
Background And Purpose: The purpose of this study was to estimate the incidence and prevalence of epilepsy among an elderly and poor population in the United States. Methods: Arizona Medicaid...